Is AstraZeneca answering German price cuts with German job cuts?
AstraZeneca ($AZN) is joining the line-up of drugmakers cutting jobs in Germany. Like the others, AZ cites the usual economic reasons, but adds a political twist. Also to blame for up to 625 job cuts? "[M]assive state intervention in the pricing of innovative medicines," the company says. AstraZeneca has had its own internal troubles in yielding new drugs from its R&D pipeline, but external factors such as drug pricing impact the industry. Article